Does the media prefer AMS or TSTL?

In the previous week, Advanced Medical Solutions Group and Advanced Medical Solutions Group both had 1 articles in the media. Advanced Medical Solutions Group's average media sentiment score of 0.95 beat Tristel's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Medical Solutions Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tristel 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is SPEC or TSTL more profitable?

Tristel has a net margin of 15.88% compared to INSPECS Group's net margin of -2.67%. Tristel's return on equity of 23.64% beat INSPECS Group's return on equity. Company Net Margins Return on Equity Return on Assets INSPECS Group -2.67% -6.07% 0.45% Tristel 15.88% 23.64% 9.89%

Do analysts rate TSTL or BVC?

Tristel currently has a consensus target price of GBX 400, indicating a potential upside of 4.99%. Given Tristel's higher possible upside, research analysts plainly believe Tristel is more favorable than BATM Advanced Communications. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tristel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 BATM Advanced Communications 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Does the media refer more to TSTL or BVC?

In the previous week, Tristel and Tristel both had 1 articles in the media. BATM Advanced Communications' average media sentiment score of 1.10 beat Tristel's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tristel 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BATM Advanced Communications 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AKR or TSTL?

Tristel has a consensus target price of GBX 400, suggesting a potential upside of 4.99%. Given Tristel's stronger consensus rating and higher probable upside, analysts clearly believe Tristel is more favorable than Akers Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akers Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tristel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend ODX or TSTL?

Tristel has a consensus target price of GBX 400, indicating a potential upside of 4.99%. Given Tristel's stronger consensus rating and higher probable upside, analysts plainly believe Tristel is more favorable than Omega Diagnostics Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omega Diagnostics Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tristel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Tristel (TSTL) Competitors

GBX 381 +6.00 (+1.60%)

As of 06/5/2026 11:50 AM Eastern

Compare

TSTL vs. AMS, SPEC, BVC, AKR, and ODX

Should you buy Tristel stock or one of its competitors? MarketBeat compares Tristel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tristel include Advanced Medical Solutions Group (AMS), INSPECS Group (SPEC), BATM Advanced Communications (BVC), Akers Biosciences (AKR), and Omega Diagnostics Group (ODX). These companies are all part of the "medical instruments & supplies" industry.

How does Tristel compare to Advanced Medical Solutions Group?

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Advanced Medical Solutions Group presently has a consensus price target of GBX 270.25, suggesting a potential upside of 24.54%. Tristel has a consensus price target of GBX 400, suggesting a potential upside of 4.99%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.2%. Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.7%. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Tristel has a net margin of 15.88% compared to Advanced Medical Solutions Group's net margin of 4.35%. Tristel's return on equity of 23.64% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
Tristel	15.88%	23.64%	9.89%

Advanced Medical Solutions Group has a beta of 0.709, suggesting that its share price is 29% less volatile than the broader market. Comparatively, Tristel has a beta of 0.333, suggesting that its share price is 67% less volatile than the broader market.

In the previous week, Advanced Medical Solutions Group and Advanced Medical Solutions Group both had 1 articles in the media. Advanced Medical Solutions Group's average media sentiment score of 0.95 beat Tristel's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Medical Solutions Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tristel	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

21.9% of Advanced Medical Solutions Group shares are held by institutional investors. Comparatively, 21.6% of Tristel shares are held by institutional investors. 4.0% of Advanced Medical Solutions Group shares are held by insiders. Comparatively, 21.0% of Tristel shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.06	£11.22M	£4.52	48.01
Tristel	£49.54M	3.69	£6.54M	£16.24	23.46

Summary

Advanced Medical Solutions Group beats Tristel on 10 of the 17 factors compared between the two stocks.

How does Tristel compare to INSPECS Group?

INSPECS Group (LON:SPEC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Tristel has lower revenue, but higher earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INSPECS Group	£191.70M	0.45	-£4.11M	-£9.40	N/A
Tristel	£49.54M	3.69	£6.54M	£16.24	23.46

Tristel has a net margin of 15.88% compared to INSPECS Group's net margin of -2.67%. Tristel's return on equity of 23.64% beat INSPECS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INSPECS Group	-2.67%	-6.07%	0.45%
Tristel	15.88%	23.64%	9.89%

0.4% of INSPECS Group shares are held by institutional investors. Comparatively, 21.6% of Tristel shares are held by institutional investors. 21.0% of INSPECS Group shares are held by company insiders. Comparatively, 21.0% of Tristel shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Tristel had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for Tristel and 0 mentions for INSPECS Group. INSPECS Group's average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company	Overall Sentiment
INSPECS Group	Neutral
Tristel	Neutral

INSPECS Group has a beta of 1.674, meaning that its share price is 67% more volatile than the broader market. Comparatively, Tristel has a beta of 0.333, meaning that its share price is 67% less volatile than the broader market.

INSPECS Group presently has a consensus target price of GBX 60, suggesting a potential downside of 28.99%. Tristel has a consensus target price of GBX 400, suggesting a potential upside of 4.99%. Given Tristel's higher probable upside, analysts clearly believe Tristel is more favorable than INSPECS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INSPECS Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Tristel beats INSPECS Group on 11 of the 15 factors compared between the two stocks.

How does Tristel compare to BATM Advanced Communications?

Tristel (LON:TSTL) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

21.6% of Tristel shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 21.0% of Tristel shares are held by insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Tristel has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tristel	£49.54M	3.69	£6.54M	£16.24	23.46
BATM Advanced Communications	£123.20M	0.35	-£278.26K	-£4.20	N/A

Tristel currently has a consensus target price of GBX 400, indicating a potential upside of 4.99%. Given Tristel's higher possible upside, research analysts plainly believe Tristel is more favorable than BATM Advanced Communications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
BATM Advanced Communications	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Tristel and Tristel both had 1 articles in the media. BATM Advanced Communications' average media sentiment score of 1.10 beat Tristel's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tristel	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BATM Advanced Communications	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tristel has a net margin of 15.88% compared to BATM Advanced Communications' net margin of -14.90%. Tristel's return on equity of 23.64% beat BATM Advanced Communications' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tristel	15.88%	23.64%	9.89%
BATM Advanced Communications	-14.90%	-22.13%	0.58%

Tristel has a beta of 0.333, meaning that its stock price is 67% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.727, meaning that its stock price is 27% less volatile than the broader market.

Summary

Tristel beats BATM Advanced Communications on 9 of the 15 factors compared between the two stocks.

How does Tristel compare to Akers Biosciences?

Akers Biosciences (LON:AKR) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Tristel has a consensus target price of GBX 400, suggesting a potential upside of 4.99%. Given Tristel's stronger consensus rating and higher probable upside, analysts clearly believe Tristel is more favorable than Akers Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akers Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tristel had 1 more articles in the media than Akers Biosciences. MarketBeat recorded 1 mentions for Tristel and 0 mentions for Akers Biosciences. Akers Biosciences' average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company	Overall Sentiment
Akers Biosciences	Neutral
Tristel	Neutral

21.6% of Tristel shares are owned by institutional investors. 21.0% of Tristel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Tristel has higher revenue and earnings than Akers Biosciences. Akers Biosciences is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akers Biosciences	£2.32M	0.00	N/A	-£129.60	N/A
Tristel	£49.54M	3.69	£6.54M	£16.24	23.46

Tristel has a net margin of 15.88% compared to Akers Biosciences' net margin of 0.00%. Tristel's return on equity of 23.64% beat Akers Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Akers Biosciences	N/A	N/A	N/A
Tristel	15.88%	23.64%	9.89%

Summary

Tristel beats Akers Biosciences on 11 of the 11 factors compared between the two stocks.

How does Tristel compare to Omega Diagnostics Group?

Omega Diagnostics Group (LON:ODX) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Tristel has a consensus target price of GBX 400, indicating a potential upside of 4.99%. Given Tristel's stronger consensus rating and higher probable upside, analysts plainly believe Tristel is more favorable than Omega Diagnostics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omega Diagnostics Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Omega Diagnostics Group has a beta of 3.85, suggesting that its share price is 285% more volatile than the broader market. Comparatively, Tristel has a beta of 0.333, suggesting that its share price is 67% less volatile than the broader market.

29.8% of Omega Diagnostics Group shares are held by institutional investors. Comparatively, 21.6% of Tristel shares are held by institutional investors. 50.6% of Omega Diagnostics Group shares are held by insiders. Comparatively, 21.0% of Tristel shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Tristel has a net margin of 15.88% compared to Omega Diagnostics Group's net margin of -51.15%. Tristel's return on equity of 23.64% beat Omega Diagnostics Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omega Diagnostics Group	-51.15%	-29.14%	-10.53%
Tristel	15.88%	23.64%	9.89%

In the previous week, Tristel had 1 more articles in the media than Omega Diagnostics Group. MarketBeat recorded 1 mentions for Tristel and 0 mentions for Omega Diagnostics Group. Omega Diagnostics Group's average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company	Overall Sentiment
Omega Diagnostics Group	Neutral
Tristel	Neutral

Tristel has higher revenue and earnings than Omega Diagnostics Group. Omega Diagnostics Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omega Diagnostics Group	£7.55M	0.00	-£3.17M	-£0.01	N/A
Tristel	£49.54M	3.69	£6.54M	£16.24	23.46

Summary

Tristel beats Omega Diagnostics Group on 10 of the 13 factors compared between the two stocks.

Get Tristel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TSTL vs. The Competition

Export

Metric	Tristel	Medical Instruments & Supplies Industry	Medical Sector	LON Exchange
Market Cap	£182.35M	£2.91B	£6.68B	£2.75B
Dividend Yield	3.74%	2.03%	2.67%	6.16%
P/E Ratio	23.46	16.49	24.06	366.37
Price / Sales	3.69	71.48	515.84	87,126.19
Price / Cash	20.96	146.54	42.23	27.85
Price / Book	5.57	2.29	9.73	7.68
Net Income	£6.54M	£99.80M	£3.57B	£5.89B
7 Day Performance	-0.39%	-1.63%	-1.28%	-0.50%
1 Month Performance	-7.12%	0.89%	1.38%	1.84%
1 Year Performance	7.35%	-8.60%	23.93%	72.87%

Tristel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TSTL Tristel	1.3734 of 5 stars	GBX 381 +1.6%	GBX 400 +5.0%	+7.4%	£182.35M	£49.54M	23.46	208	News Coverage
AMS Advanced Medical Solutions Group	2.9276 of 5 stars	GBX 220 +0.5%	GBX 270.25 +22.8%	+2.4%	£477.21M	£228.94M	48.67	10
SPEC INSPECS Group	0.4771 of 5 stars	GBX 82 -1.8%	GBX 60 -26.8%	+72.5%	£83.37M	£191.70M	N/A	1,673
BVC BATM Advanced Communications	1.3804 of 5 stars	GBX 13.60 -1.1%	N/A	-29.8%	£46.25M	£123.20M	N/A	980	News Coverage
AKR Akers Biosciences	N/A	N/A	N/A	N/A	£21.64M	£2.32M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:TSTL) was last updated on 6/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tristel (TSTL) Competitors

TSTL vs. AMS, SPEC, BVC, AKR, and ODX

How does Tristel compare to Advanced Medical Solutions Group?

Summary

How does Tristel compare to INSPECS Group?

Summary

How does Tristel compare to BATM Advanced Communications?

Summary

How does Tristel compare to Akers Biosciences?

Summary

How does Tristel compare to Omega Diagnostics Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TSTL vs. The Competition

Tristel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tristel (TSTL) Competitors

TSTL vs. AMS, SPEC, BVC, AKR, and ODX

How does Tristel compare to Advanced Medical Solutions Group?

Do analysts prefer AMS or TSTL?

Is AMS or TSTL a better dividend stock?

Is AMS or TSTL more profitable?

Which has more risk and volatility, AMS or TSTL?

Does the media prefer AMS or TSTL?

Do insiders & institutionals have more ownership in AMS or TSTL?

Which has stronger valuation and earnings, AMS or TSTL?

Summary

How does Tristel compare to INSPECS Group?

Which has preferable earnings & valuation, SPEC or TSTL?

Is SPEC or TSTL more profitable?

Do institutionals and insiders hold more shares of SPEC or TSTL?

Does the media refer more to SPEC or TSTL?

Which has more risk & volatility, SPEC or TSTL?

Do analysts recommend SPEC or TSTL?

Summary

How does Tristel compare to BATM Advanced Communications?

Do institutionals and insiders believe in TSTL or BVC?

Which has higher valuation & earnings, TSTL or BVC?

Do analysts rate TSTL or BVC?

Does the media refer more to TSTL or BVC?

Is TSTL or BVC more profitable?

Which has more risk and volatility, TSTL or BVC?

Summary

How does Tristel compare to Akers Biosciences?

Do analysts prefer AKR or TSTL?

Does the media favor AKR or TSTL?

Do institutionals and insiders hold more shares of AKR or TSTL?

Which has better earnings and valuation, AKR or TSTL?

Is AKR or TSTL more profitable?

Summary

How does Tristel compare to Omega Diagnostics Group?

Do analysts recommend ODX or TSTL?

Which has more risk and volatility, ODX or TSTL?

Do insiders & institutionals have more ownership in ODX or TSTL?

Is ODX or TSTL more profitable?

Does the media favor ODX or TSTL?

Which has preferable valuation & earnings, ODX or TSTL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TSTL vs. The Competition

Tristel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools